NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024

NHS EnglandcontractContracts FinderRef CF-2202100D0O000000rwimUAASME suitablecomplete

Estimated value

£580.2m

Awarded value

£688.0m

Awarded 26 Jan 2024

Suppliers

1

Lots

1

1 awarded

Published

26 Feb 2024

Deadline 22 Nov 2023

Other contracts from NHS England· 10

Most recent notices published by the same contracting authority.

View buyer profile →

Other contracts awarded to Zentiva Pharma UK Ltd,GlaxoSmithKline UK Limited,Celltrion Healthcare United Kingdom Limited,Biogen,Kent Pharma Ltd,Amgen Ltd,Merck Sharpe & Dohme (UK) Limited,Accord-UK Ltd,Neon Healthcare Ltd,Dr.Reddy's Laboratories (UK) Limited,Pfizer Ltd,Bayer Plc,Sandoz Ltd,Aventis Pharma ltd t/a Sanofi,Vifor Pharma UK Ltd,Chugai Pharma UK Ltd,Sun Pharma UK Ltd,Sobi (Swedish Orphan Biovitrum Ltd),Mylan,Galapagos Biotech Ltd,Abbvie Ltd,Thornton and Ross Ltd,Merck Serono Limited,AstraZeneca,Janssen-Cilag Ltd,Eli Lilly & Company Ltd,Roche Products Ltd,Ipsen,Organon Pharmaceuticals UK Ltd,Almirall,Merz,Napp Pharmaceuticals Ltd,CST Pharma Limited,Pharmacosmos UK Ltd,Orifarm UK,Teva UK Limited,Novo Nordisk,Novartis Pharmaceuticals UK Ltd,Gedeon Richter UK Ltd· 0

Cross-buyer view of this supplier's public-sector wins.

View supplier profile →

No related contracts found.